Skip to content

Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database

Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention: Analysis of the Korean Nationwide Health Insurance Database

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04778969
Enrollment
200000
Registered
2021-03-03
Start date
2021-04-01
Completion date
2021-04-01
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Drug-coated Balloon, Drug-eluting Stents

Brief summary

Current Status and Prognosis of Coronary artery disease patients treated with coronary intervention - Analysis of the Korean Nationwide Health Insurance Database

Detailed description

This is a retrospective study and is conducted for all patients who received percutaneous coronary intervention among cohorts registered with the National Health Insurance Service. Primary outcome is all cause of mortality. Secondary outcomes are cardiovascular death, ischemic stroke, cerebral hemorrhage, admission due to gastrointestinal bleeding, and admission due to major bleedings.

Interventions

DEVICEdrug-eluting stent

A group of percutaneous coronary intervention (PCI) using drug-eluting stents (DES)

DEVICEdrug-coated balloon

A group of percutaneous coronary intervention (PCI) using drug-coated balloon (DCB)

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All coronary artery disease patients wih Korean NHIS (National Health Insurance Service)-listed PCI

Exclusion criteria

* non-specified

Design outcomes

Primary

MeasureTime frameDescription
All cause of death10 years'All cause of death' will be recorded as number of participants with 'All cause of death'

Secondary

MeasureTime frameDescription
Cardiovascular death10 years'Cardiovascular death' will be recorded as number of participants with 'Cardiovascular death'
ischemic stroke10 years'ischemic stroke' will be recorded as number of participants with 'ischemic stroke'
Cerebral hemorrhage10 years'Cerebral hemorrhage' will be recorded as number of participants with 'Cerebral hemorrhage'
Admission due to gastrointestinal bleeding10 years'Admission due to gastrointestinal bleeding' will be recorded as number of participants with 'Admission due to gastrointestinal bleeding'
Admission due to major bleeding10 years'Admission due to major bleeding' will be recorded as number of participants with 'Admission due to major bleeding' Thismeasure is a composite outcome, which includes cerebral hemorrhage, admission due to gastrointestinal bleeding.

Contacts

Primary ContactHan-Mo Yang, MD, PhD
hanname@gmail.com8220722677
Backup ContactHak Seung Lee, MD
cardiolee@gmail.com821031668399

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026